ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

Ultrasound Shown to be Superior Diagnostic Compared to Mammography in Women Ages 30-39

October 26, 2012

NIEHS Conference to Look At 21st Century Issues

April 1, 1988

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

Appropriations: NIH Professional Needs Budget Gains Attention

March 14, 1997

RF Numbers To Drop Noticeably Soon, Upton Tells AACR

April 14, 1978

Editorial: Rumor Mill Fills The Gap When Access Denied

December 16, 1994